These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33441889)

  • 21. MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism.
    Sugiyama A; Sato N; Kimura Y; Ota M; Maekawa T; Sone D; Enokizono M; Murata M; Matsuda H; Kuwabara S
    Parkinsonism Relat Disord; 2018 Mar; 48():10-16. PubMed ID: 29279191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.
    Wang J; Li Y; Huang Z; Wan W; Zhang Y; Wang C; Cheng X; Ye F; Liu K; Fei G; Zeng M; Jin L
    Eur J Neurol; 2018 Jul; 25(7):949-e73. PubMed ID: 29520900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Imaging in Parkinson's Disease: New Developments.
    Prange S; Metereau E; Thobois S
    Curr Neurol Neurosci Rep; 2019 Jun; 19(8):50. PubMed ID: 31214847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Substantia Nigra morphology in Parkinson's Disease.
    Durmaz Çelik N; Yaman Kula A; Toprak U; Saylısoy S; Topal A; Özkan S
    Medicine (Baltimore); 2024 Mar; 103(12):e37538. PubMed ID: 38518035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of SWI sequences compared to T2*-weighted gradient echo sequences in the detection of cerebral cavernous malformations in the familial form.
    Sparacia G; Speciale C; Banco A; Bencivinni F; Midiri M
    Neuroradiol J; 2016 Oct; 29(5):326-35. PubMed ID: 27549150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ultra early diagnosis of Parkinson's disease by the enhanced substantia nigra echo.
    Zhuang JJ; Zheng YH; Xu XW; Zhou L
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4621-6. PubMed ID: 26698260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative MR evaluation of intracranial epidermoid tumors by fast fluid-attenuated inversion recovery imaging and echo-planar diffusion-weighted imaging.
    Chen S; Ikawa F; Kurisu K; Arita K; Takaba J; Kanou Y
    AJNR Am J Neuroradiol; 2001; 22(6):1089-96. PubMed ID: 11415903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visualization of nigrosomes-1 in 3T MR susceptibility weighted imaging and its absence in diagnosing Parkinson's disease.
    Gao P; Zhou PY; Li G; Zhang GB; Wang PQ; Liu JZ; Xu F; Yang F; Wu XX
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4603-9. PubMed ID: 26698258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI).
    Nam Y; Gho SM; Kim DH; Kim EY; Lee J
    J Magn Reson Imaging; 2017 Aug; 46(2):528-536. PubMed ID: 27859983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.
    Guan X; Xu X; Zhang M
    Neurosci Bull; 2017 Oct; 33(5):561-567. PubMed ID: 28516282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging.
    Hutchinson M; Raff U
    AJNR Am J Neuroradiol; 2000 Apr; 21(4):697-701. PubMed ID: 10782780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late Stage.
    Du G; Wang E; Sica C; Chen H; De Jesus S; Lewis MM; Kong L; Connor J; Mailman RB; Huang X
    Mov Disord; 2022 Aug; 37(8):1654-1662. PubMed ID: 35614551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
    Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
    Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
    Schwarz ST; Rittman T; Gontu V; Morgan PS; Bajaj N; Auer DP
    Mov Disord; 2011 Aug; 26(9):1633-8. PubMed ID: 21491489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nigrosome 1 visibility at susceptibility weighted 7T MRI-A dependable diagnostic marker for Parkinson's disease or merely an inconsistent, age-dependent imaging finding?
    Gramsch C; Reuter I; Kraff O; Quick HH; Tanislav C; Roessler F; Deuschl C; Forsting M; Schlamann M
    PLoS One; 2017; 12(10):e0185489. PubMed ID: 29016618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fast fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging of the brain: a comparison of multi-shot echo-planar and fast spin-echo techniques.
    Sargent MA; Poskitt KJ
    Pediatr Radiol; 1997 Jun; 27(6):545-9. PubMed ID: 9174030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Universality analysis of the existence of substantia nigra "swallow tail" appearance of non-Parkinson patients in 3T SWI.
    Gao P; Zhou PY; Wang PQ; Zhang GB; Liu JZ; Xu F; Yang F; Wu XX; Li G
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1307-14. PubMed ID: 27097951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.